Crown Laboratories announced that is has restructured its commercial operations business units as it continues to elevate its new "Skin Science for Life" commitment. After acquiring its Beauty and Aesthetic divisions (formerly Vita Liberata and Bellus Medical, respectively), and strengthening its therapeutics portfolio through acquisition of six consumer heritage brands from GlaxoSmithKline, Crown is now poised to become a global leader in dermatology health and wellness.
Skin Science for Life is Crown's commitment to providing healthcare professionals, their patients, and all others with science-driven skin-health solutions no matter their stage of life. "The improved structure and naming convention of these business units allows for a more memorable, distinct alignment within our organization," says Jeff Bedard, President and CEO of Crown. "We believe the power of team is far greater than the power of one, and by incorporating Crown into each of our business unit names, we are ensuring our customers recognize the greater team that stands with them. Whether patients require a therapeutic solution, are seeking an aesthetic treatment or beauty need, Crown is here to fulfill those needs."
Here are Crown’s new global commercial business divisions:
Formerly Bellus Medical, which offers SkinPen, SKINFUSE, ProGen PRP, and Allumera.
Formerly Vita Liberata Limited, makers of Vita Liberata and NKD SKN sunless-tanning beauty products.
New unit comprising of Blue Lizard Australian Sunscreen, PanOxyl, Sarna, and several other therapeutics brands.